tirzepatide ban compound update 📢Important FDA Update on Compounded Tirzepatide! Due to recent FDA regulations, 💉 Here's what they don't

Take the first dose in the morning and the second dose in the afternoon

Cases of cyclosporiasis, a pathogen often caused by contaminated produce, are rising across several U.S

GLP1 pens do not all work the same way

Sergey Terushkin, MD, FACS, you receive trusted medical oversight and medication sourced only from licensed U.S

Free GLP-1 Case Evaluation.

FDAs Landmark Approval for GLP-1 Therapy How GLP-1's Address OSA in Healthcare Technology Potential Side Effects and Safety Warnings Wespers Role in Emerging OSA Treatments FDAs Landmark Approval for GLP-1 TherapyOn December 20, 2024, the Food and Drug Administration (FDAs official press announcement) recognized a major milestone by approving Zepbound(tirzepatide) for adults with moderate to severe obstructive sleep apnea